Why Do Some CGT Companies Make It and Others End Up as Slide Decks?
It’s not just the tech. It’s not just the team. It’s knowing why you’re building in CGT and how to survive the regulatory gauntlet, investor mood swings, and the reality of manufacturing what you promised.
This conference isn’t about big claims and vague visions. It’s for the people in the trenches the ones raising Series A with 18 months of runway and 6 months of data, the ones explaining viral vectors to board members who still think DNA is proprietary.
We’re gathering the founders, therapy developers, and strategic minds behind the CGT companies that actually get built. If that’s you, or who you’re trying to become, save the date. You’ll want to be in the room.
The Conversations CGT Leaders Have Been Waiting For
If you’re building a CGT company, you’ve probably felt it: most events skim the surface or stay stuck in science. But what’s missing is a place to talk about the real decisions; the ones that shape your company long before commercial launch.
This conference was built to fill that gap.
In CGT, success isn’t just about innovation. It’s about building the right company around it.
It’s where founders, operators, and strategic leads come together to share how they’re preparing for partnerships, navigating regulatory risks, planning for manufacturing before it’s urgent, and thinking commercially from day one.
It’s the kind of gathering where people stop pitching and start trading lessons about what’s worked, what hasn’t, and what they wish they’d known a year earlier.
Who should join?
This event is built for people shaping CGT companies from the inside out.
- Founders making hard calls on funding and focus.
- Commercial leads figuring out how to position what’s still in development.
- Regulatory and CMC leads translating ambition into approvals.
- Investors who know the next big thing won’t look like the last one.
If you’re building, backing, or scaling in CGT —you belong here.
What It Really Takes to Build a CGT Company
This conference brings together the knowledge needed to move from concept to clinic with focus and clarity. Sessions explore how teams manage regulatory timelines, structure their CMC and nonclinical work to avoid rework, and make smart choices around data, vendors, and internal capabilities.
It’s about the operational details, the strategic planning, and the small decisions that quietly determine whether a therapy makes it to patients or stalls before it gets there.
The Location — PLNT Leiden
Our venue is PLNT, the heart of innovation in Leiden’s biotech ecosystem. Located just minutes from Leiden Central Station, PLNT brings together startups, scale-ups, and forward-looking thinkers in life sciences and tech. With modern facilities, flexible spaces, and a rooftop view over the city, it’s built for collaboration and sharp conversations; exactly the kind of environment where the future of CGT belongs.
The Program — Designed for Execution
Besides keynote talks from CGT veterans who’ve built, led, and scaled programs across development stages, the program runs in parallel streams focused on clinical strategy, regulatory progress, and CMC readiness. Each session will offer hands-on insight into planning, coordination, and decision-making.
Alongside the main program, you’ll find a curated carousel of emerging enabling technologies, expert-led workshops on critical topics, and dedicated space for 1:1 partnering conversations grounded in real expertise.
It’s a working agenda for teams actively building the next generation of CGT companies.